DSC ADVISORS L P
Q4 2019 Form 13-F
CHICAGO, ILLINOIS
CIK 0001299434
· CRD 158312
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2017
$208.7M Reported Value Total
DSC ADVISORS, L.P. reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $380,873,577, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
6 funds
· $483.9M gross asset value
Hedge Fund: $483.9M
Source: Form ADV filed 2020-02-14
Reported value
$208.7M
Quarter over quarter
+11.4%
Holdings
79
Top-10 concentration
65.1%
Filing Structure
Reports holdings for
- DSCQG PR LLC · File #028-18129 · since Q2 2017
- DSCQG PR LLC (not a 13F filer in our records) · Q4 2016 – Q1 2017 · declared by one filing
- DACQG PR LLC (not a 13F filer in our records) · Q3 2016 – Q3 2016 · declared by one filing
- DSC Quantitative Group, LLC (not a 13F filer in our records) · Q2 2013 – Q2 2016 · declared by one filing
Key People
Form ADV owners & control persons
Andrew Gordon Bluhm
PRINCIPAL
Amy Catherine Close
CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2019 13F record
Q4 2019 13F filing summary
| Period of report | December 31, 2019 |
|---|---|
| Filed | February 14, 2020 |
| Form | 13F-HR |
| Reported value | $208.7M |
| Positions | 79 |
| Change in reported value | -58.7% |
| New positions | 15 |
| Exited positions | 14 |
| Position turnover | 31.2% |
| Top-10 concentration | 65.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 14, 2024
|
19 | $11.0M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
23 | $30.0M |
|
Q1 2024 13F
Filed May 15, 2024
|
30 | $62.6M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $60.5M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
26 | $77.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
25 | $66.7M |
|
Q1 2023 13F
Filed May 15, 2023
|
19 | $114.5M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
15 | $43.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
93 | $97.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
109 | $100.1M |
|
Q1 2022 13F
Filed May 16, 2022
|
127 | $290.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
68 | $129.4M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
68 | $98.5M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
65 | $138.4M |
|
Q1 2021 13F
Filed May 14, 2021
|
75 | $161.4M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
40 | $120.9M |
|
Q3 2020 13F
Filed Nov 16, 2020
|
39 | $149.5M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
29 | $91.2M |
|
Q1 2020 13F
Filed May 15, 2020
|
28 | $102.4M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
79 | $208.7M |
26 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2019
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ATH ATHENE HLDG LTD | $26.1M | 12.48% |
| 2 | MS MORGAN STANLEY | $17.1M | 8.2% |
| 3 | GOOG ALPHABET INC | $15.4M | 7.37% |
| 4 | CVS CVS HEALTH CORP | $13.3M | 6.37% |
| 5 | ZBH ZIMMER BIOMET HLDGS INC | $11.7M | 5.62% |
| 6 | DAL DELTA AIR LINES INC DEL | $11.7M | 5.6% |
| 7 | COR AMERISOURCEBERGEN CORP | $11.4M | 5.46% |
| 8 | FOMX FOAMIX PHARMACEUTICALS LTD | $11.2M | 5.37% |
| 9 | DVA DAVITA INC | $9.8M | 4.67% |
| 10 | DISCA DISCOVERY INC | $8.2M | 3.92% |
| 11 | ACEL ACCEL ENTMT INC | $8.1M | 3.89% |
| 12 | ALXN ALEXION PHARMACEUTICALS INC | $7.4M | 3.55% |
| 13 | NIO P NIO INC | $4.8M | 2.31% |
| 14 | BMY BRISTOL MYERS SQUIBB CO | $4.6M | 2.19% |
| 15 | CVS C CVS HEALTH CORP | $4.5M | 2.17% |
| 16 | MSFT MICROSOFT CORP | $2.3M | 1.08% |
| 17 | GOOGL ALPHABET INC | $2.2M | 1.07% |
| 18 | META FACEBOOK INC | $1.9M | 0.92% |
| 19 | V VISA INC | $1.8M | 0.84% |
| 20 | MA MASTERCARD INC | $1.7M | 0.82% |
Values as reported on the Q4 2019 Form 13F. Every position is in the holdings table below.